ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Live Attenuated Vaccines for Poultry Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-0A11768
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Live Attenuated Vaccines for Poultry Market Research Report 2022
BUY CHAPTERS

Global Live Attenuated Vaccines for Poultry Market Research Report 2024

Code: QYRE-Auto-0A11768
Report
May 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Boehringer Ingelheim
Elanco
QYH Biotech
Ceva
Hipra
Zoetis Inc
Vaxxinova
Pulike
Phibro Animal Health Corporation
Jinyu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Kemin Biologics

Live Attenuated Vaccines for Poultry Market Size

The global Live Attenuated Vaccines for Poultry market was valued at US$ 341.1 million in 2023 and is anticipated to reach US$ 456.2 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.

Live Attenuated Vaccines for Poultry Market

Live Attenuated Vaccines for Poultry Market

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 612%.
This report aims to provide a comprehensive presentation of the global market for Live Attenuated Vaccines for Poultry, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Vaccines for Poultry.

Report Scope

The Live Attenuated Vaccines for Poultry market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Live Attenuated Vaccines for Poultry market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Attenuated Vaccines for Poultry manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Live Attenuated Vaccines for Poultry Market Report

Report Metric Details
Report Name Live Attenuated Vaccines for Poultry Market
Accounted market size in 2023 US$ 341.1 million
Forecasted market size in 2030 US$ 456.2 million
CAGR 4.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Spray
  • Eye Drop
  • Oral
  • Others
Segment by Application
  • Chicken
  • Cattle
  • Horse
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, HIPRA, Kemin Biologics, ZOETIS, Vaxxinova, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, JINYU BIOTECHNOLOGY, HARBIN PHARMACEUTICAL GROUP, MEVAC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Live Attenuated Vaccines for Poultry manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Live Attenuated Vaccines for Poultry in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Live Attenuated Vaccines for Poultry Market growing?

Ans: The Live Attenuated Vaccines for Poultry Market witnessing a CAGR of 4.3% during the forecast period 2024-2030.

What is the Live Attenuated Vaccines for Poultry Market size in 2030?

Ans: The Live Attenuated Vaccines for Poultry Market size in 2030 will be US$ 456.2 million.

Who are the main players in the Live Attenuated Vaccines for Poultry Market report?

Ans: The main players in the Live Attenuated Vaccines for Poultry Market are MERCK, Boehringer Ingelheim, ELANCO, QYH BIOTECH, CEVA, HIPRA, Kemin Biologics, ZOETIS, Vaxxinova, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, JINYU BIOTECHNOLOGY, HARBIN PHARMACEUTICAL GROUP, MEVAC

What are the Application segmentation covered in the Live Attenuated Vaccines for Poultry Market report?

Ans: The Applications covered in the Live Attenuated Vaccines for Poultry Market report are Chicken, Cattle, Horse, Others

What are the Type segmentation covered in the Live Attenuated Vaccines for Poultry Market report?

Ans: The Types covered in the Live Attenuated Vaccines for Poultry Market report are Spray, Eye Drop, Oral, Others

1 Live Attenuated Vaccines for Poultry Market Overview
1.1 Product Overview and Scope of Live Attenuated Vaccines for Poultry
1.2 Live Attenuated Vaccines for Poultry Segment by Type
1.2.1 Global Live Attenuated Vaccines for Poultry Market Value Comparison by Type (2024-2030)
1.2.2 Spray
1.2.3 Eye Drop
1.2.4 Oral
1.2.5 Others
1.3 Live Attenuated Vaccines for Poultry Segment by Application
1.3.1 Global Live Attenuated Vaccines for Poultry Market Value by Application: (2024-2030)
1.3.2 Chicken
1.3.3 Cattle
1.3.4 Horse
1.3.5 Others
1.4 Global Live Attenuated Vaccines for Poultry Market Size Estimates and Forecasts
1.4.1 Global Live Attenuated Vaccines for Poultry Revenue 2019-2030
1.4.2 Global Live Attenuated Vaccines for Poultry Sales 2019-2030
1.4.3 Global Live Attenuated Vaccines for Poultry Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Live Attenuated Vaccines for Poultry Market Competition by Manufacturers
2.1 Global Live Attenuated Vaccines for Poultry Sales Market Share by Manufacturers (2019-2024)
2.2 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Live Attenuated Vaccines for Poultry Average Price by Manufacturers (2019-2024)
2.4 Global Live Attenuated Vaccines for Poultry Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Product Type & Application
2.7 Live Attenuated Vaccines for Poultry Market Competitive Situation and Trends
2.7.1 Live Attenuated Vaccines for Poultry Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Live Attenuated Vaccines for Poultry Players Market Share by Revenue
2.7.3 Global Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Live Attenuated Vaccines for Poultry Retrospective Market Scenario by Region
3.1 Global Live Attenuated Vaccines for Poultry Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Live Attenuated Vaccines for Poultry Global Live Attenuated Vaccines for Poultry Sales by Region: 2019-2030
3.2.1 Global Live Attenuated Vaccines for Poultry Sales by Region: 2019-2024
3.2.2 Global Live Attenuated Vaccines for Poultry Sales by Region: 2025-2030
3.3 Global Live Attenuated Vaccines for Poultry Global Live Attenuated Vaccines for Poultry Revenue by Region: 2019-2030
3.3.1 Global Live Attenuated Vaccines for Poultry Revenue by Region: 2019-2024
3.3.2 Global Live Attenuated Vaccines for Poultry Revenue by Region: 2025-2030
3.4 North America Live Attenuated Vaccines for Poultry Market Facts & Figures by Country
3.4.1 North America Live Attenuated Vaccines for Poultry Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Live Attenuated Vaccines for Poultry Sales by Country (2019-2030)
3.4.3 North America Live Attenuated Vaccines for Poultry Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Attenuated Vaccines for Poultry Market Facts & Figures by Country
3.5.1 Europe Live Attenuated Vaccines for Poultry Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Live Attenuated Vaccines for Poultry Sales by Country (2019-2030)
3.5.3 Europe Live Attenuated Vaccines for Poultry Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Attenuated Vaccines for Poultry Market Facts & Figures by Country
3.6.1 Asia Pacific Live Attenuated Vaccines for Poultry Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Live Attenuated Vaccines for Poultry Sales by Country (2019-2030)
3.6.3 Asia Pacific Live Attenuated Vaccines for Poultry Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Live Attenuated Vaccines for Poultry Market Facts & Figures by Country
3.7.1 Latin America Live Attenuated Vaccines for Poultry Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Live Attenuated Vaccines for Poultry Sales by Country (2019-2030)
3.7.3 Latin America Live Attenuated Vaccines for Poultry Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Live Attenuated Vaccines for Poultry Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Attenuated Vaccines for Poultry Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Live Attenuated Vaccines for Poultry Sales by Country (2019-2030)
3.8.3 Middle East and Africa Live Attenuated Vaccines for Poultry Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Attenuated Vaccines for Poultry Sales by Type (2019-2030)
4.1.1 Global Live Attenuated Vaccines for Poultry Sales by Type (2019-2024)
4.1.2 Global Live Attenuated Vaccines for Poultry Sales by Type (2025-2030)
4.1.3 Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2019-2030)
4.2 Global Live Attenuated Vaccines for Poultry Revenue by Type (2019-2030)
4.2.1 Global Live Attenuated Vaccines for Poultry Revenue by Type (2019-2024)
4.2.2 Global Live Attenuated Vaccines for Poultry Revenue by Type (2025-2030)
4.2.3 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2019-2030)
4.3 Global Live Attenuated Vaccines for Poultry Price by Type (2019-2030)
5 Segment by Application
5.1 Global Live Attenuated Vaccines for Poultry Sales by Application (2019-2030)
5.1.1 Global Live Attenuated Vaccines for Poultry Sales by Application (2019-2024)
5.1.2 Global Live Attenuated Vaccines for Poultry Sales by Application (2025-2030)
5.1.3 Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2019-2030)
5.2 Global Live Attenuated Vaccines for Poultry Revenue by Application (2019-2030)
5.2.1 Global Live Attenuated Vaccines for Poultry Revenue by Application (2019-2024)
5.2.2 Global Live Attenuated Vaccines for Poultry Revenue by Application (2025-2030)
5.2.3 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2019-2030)
5.3 Global Live Attenuated Vaccines for Poultry Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MERCK
6.1.1 MERCK Corporation Information
6.1.2 MERCK Description and Business Overview
6.1.3 MERCK Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MERCK Live Attenuated Vaccines for Poultry Product Portfolio
6.1.5 MERCK Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 ELANCO
6.3.1 ELANCO Corporation Information
6.3.2 ELANCO Description and Business Overview
6.3.3 ELANCO Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ELANCO Live Attenuated Vaccines for Poultry Product Portfolio
6.3.5 ELANCO Recent Developments/Updates
6.4 QYH BIOTECH
6.4.1 QYH BIOTECH Corporation Information
6.4.2 QYH BIOTECH Description and Business Overview
6.4.3 QYH BIOTECH Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.4.4 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Portfolio
6.4.5 QYH BIOTECH Recent Developments/Updates
6.5 CEVA
6.5.1 CEVA Corporation Information
6.5.2 CEVA Description and Business Overview
6.5.3 CEVA Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CEVA Live Attenuated Vaccines for Poultry Product Portfolio
6.5.5 CEVA Recent Developments/Updates
6.6 HIPRA
6.6.1 HIPRA Corporation Information
6.6.2 HIPRA Description and Business Overview
6.6.3 HIPRA Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HIPRA Live Attenuated Vaccines for Poultry Product Portfolio
6.6.5 HIPRA Recent Developments/Updates
6.7 Kemin Biologics
6.6.1 Kemin Biologics Corporation Information
6.6.2 Kemin Biologics Description and Business Overview
6.6.3 Kemin Biologics Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kemin Biologics Live Attenuated Vaccines for Poultry Product Portfolio
6.7.5 Kemin Biologics Recent Developments/Updates
6.8 ZOETIS
6.8.1 ZOETIS Corporation Information
6.8.2 ZOETIS Description and Business Overview
6.8.3 ZOETIS Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ZOETIS Live Attenuated Vaccines for Poultry Product Portfolio
6.8.5 ZOETIS Recent Developments/Updates
6.9 Vaxxinova
6.9.1 Vaxxinova Corporation Information
6.9.2 Vaxxinova Description and Business Overview
6.9.3 Vaxxinova Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vaxxinova Live Attenuated Vaccines for Poultry Product Portfolio
6.9.5 Vaxxinova Recent Developments/Updates
6.10 PULIKE
6.10.1 PULIKE Corporation Information
6.10.2 PULIKE Description and Business Overview
6.10.3 PULIKE Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PULIKE Live Attenuated Vaccines for Poultry Product Portfolio
6.10.5 PULIKE Recent Developments/Updates
6.11 PHIBRO ANIMAL HEALTH CORPORATION
6.11.1 PHIBRO ANIMAL HEALTH CORPORATION Corporation Information
6.11.2 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Description and Business Overview
6.11.3 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.11.4 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Portfolio
6.11.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
6.12 JINYU BIOTECHNOLOGY
6.12.1 JINYU BIOTECHNOLOGY Corporation Information
6.12.2 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Description and Business Overview
6.12.3 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.12.4 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Portfolio
6.12.5 JINYU BIOTECHNOLOGY Recent Developments/Updates
6.13 HARBIN PHARMACEUTICAL GROUP
6.13.1 HARBIN PHARMACEUTICAL GROUP Corporation Information
6.13.2 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Description and Business Overview
6.13.3 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.13.4 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Portfolio
6.13.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
6.14 MEVAC
6.14.1 MEVAC Corporation Information
6.14.2 MEVAC Live Attenuated Vaccines for Poultry Description and Business Overview
6.14.3 MEVAC Live Attenuated Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.14.4 MEVAC Live Attenuated Vaccines for Poultry Product Portfolio
6.14.5 MEVAC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Attenuated Vaccines for Poultry Industry Chain Analysis
7.2 Live Attenuated Vaccines for Poultry Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Attenuated Vaccines for Poultry Production Mode & Process
7.4 Live Attenuated Vaccines for Poultry Sales and Marketing
7.4.1 Live Attenuated Vaccines for Poultry Sales Channels
7.4.2 Live Attenuated Vaccines for Poultry Distributors
7.5 Live Attenuated Vaccines for Poultry Customers
8 Live Attenuated Vaccines for Poultry Market Dynamics
8.1 Live Attenuated Vaccines for Poultry Industry Trends
8.2 Live Attenuated Vaccines for Poultry Market Drivers
8.3 Live Attenuated Vaccines for Poultry Market Challenges
8.4 Live Attenuated Vaccines for Poultry Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Boehringer Ingelheim
Elanco
QYH Biotech
Ceva
Hipra
Zoetis Inc
Vaxxinova
Pulike
Phibro Animal Health Corporation
Jinyu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Kemin Biologics
List of Tables
    Table 1. Global Live Attenuated Vaccines for Poultry Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Live Attenuated Vaccines for Poultry Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Live Attenuated Vaccines for Poultry Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Live Attenuated Vaccines for Poultry Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Live Attenuated Vaccines for Poultry Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Live Attenuated Vaccines for Poultry Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Live Attenuated Vaccines for Poultry Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Live Attenuated Vaccines for Poultry Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Live Attenuated Vaccines for Poultry, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Product Type & Application
    Table 12. Global Key Manufacturers of Live Attenuated Vaccines for Poultry, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Live Attenuated Vaccines for Poultry by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Vaccines for Poultry as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Live Attenuated Vaccines for Poultry Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Live Attenuated Vaccines for Poultry Sales by Region (2019-2024) & (K Units)
    Table 18. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2019-2024)
    Table 19. Global Live Attenuated Vaccines for Poultry Sales by Region (2025-2030) & (K Units)
    Table 20. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2025-2030)
    Table 21. Global Live Attenuated Vaccines for Poultry Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2019-2024)
    Table 23. Global Live Attenuated Vaccines for Poultry Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2025-2030)
    Table 25. North America Live Attenuated Vaccines for Poultry Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Live Attenuated Vaccines for Poultry Sales by Country (2019-2024) & (K Units)
    Table 27. North America Live Attenuated Vaccines for Poultry Sales by Country (2025-2030) & (K Units)
    Table 28. North America Live Attenuated Vaccines for Poultry Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Live Attenuated Vaccines for Poultry Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Live Attenuated Vaccines for Poultry Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Live Attenuated Vaccines for Poultry Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Live Attenuated Vaccines for Poultry Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Live Attenuated Vaccines for Poultry Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Live Attenuated Vaccines for Poultry Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Live Attenuated Vaccines for Poultry Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Live Attenuated Vaccines for Poultry Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Live Attenuated Vaccines for Poultry Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Live Attenuated Vaccines for Poultry Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Live Attenuated Vaccines for Poultry Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Live Attenuated Vaccines for Poultry Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Live Attenuated Vaccines for Poultry Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Live Attenuated Vaccines for Poultry Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Live Attenuated Vaccines for Poultry Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Live Attenuated Vaccines for Poultry Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Live Attenuated Vaccines for Poultry Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Live Attenuated Vaccines for Poultry Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Live Attenuated Vaccines for Poultry Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Live Attenuated Vaccines for Poultry Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Live Attenuated Vaccines for Poultry Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Live Attenuated Vaccines for Poultry Sales (K Units) by Type (2019-2024)
    Table 51. Global Live Attenuated Vaccines for Poultry Sales (K Units) by Type (2025-2030)
    Table 52. Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2019-2024)
    Table 53. Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2025-2030)
    Table 54. Global Live Attenuated Vaccines for Poultry Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Live Attenuated Vaccines for Poultry Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2019-2024)
    Table 57. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Type (2025-2030)
    Table 58. Global Live Attenuated Vaccines for Poultry Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Live Attenuated Vaccines for Poultry Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Live Attenuated Vaccines for Poultry Sales (K Units) by Application (2019-2024)
    Table 61. Global Live Attenuated Vaccines for Poultry Sales (K Units) by Application (2025-2030)
    Table 62. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2019-2024)
    Table 63. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2025-2030)
    Table 64. Global Live Attenuated Vaccines for Poultry Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Live Attenuated Vaccines for Poultry Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2019-2024)
    Table 67. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Application (2025-2030)
    Table 68. Global Live Attenuated Vaccines for Poultry Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Live Attenuated Vaccines for Poultry Price (US$/Unit) by Application (2025-2030)
    Table 70. MERCK Corporation Information
    Table 71. MERCK Description and Business Overview
    Table 72. MERCK Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. MERCK Live Attenuated Vaccines for Poultry Product
    Table 74. MERCK Recent Developments/Updates
    Table 75. Boehringer Ingelheim Corporation Information
    Table 76. Boehringer Ingelheim Description and Business Overview
    Table 77. Boehringer Ingelheim Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product
    Table 79. Boehringer Ingelheim Recent Developments/Updates
    Table 80. ELANCO Corporation Information
    Table 81. ELANCO Description and Business Overview
    Table 82. ELANCO Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. ELANCO Live Attenuated Vaccines for Poultry Product
    Table 84. ELANCO Recent Developments/Updates
    Table 85. QYH BIOTECH Corporation Information
    Table 86. QYH BIOTECH Description and Business Overview
    Table 87. QYH BIOTECH Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. QYH BIOTECH Live Attenuated Vaccines for Poultry Product
    Table 89. QYH BIOTECH Recent Developments/Updates
    Table 90. CEVA Corporation Information
    Table 91. CEVA Description and Business Overview
    Table 92. CEVA Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. CEVA Live Attenuated Vaccines for Poultry Product
    Table 94. CEVA Recent Developments/Updates
    Table 95. HIPRA Corporation Information
    Table 96. HIPRA Description and Business Overview
    Table 97. HIPRA Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. HIPRA Live Attenuated Vaccines for Poultry Product
    Table 99. HIPRA Recent Developments/Updates
    Table 100. Kemin Biologics Corporation Information
    Table 101. Kemin Biologics Description and Business Overview
    Table 102. Kemin Biologics Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Kemin Biologics Live Attenuated Vaccines for Poultry Product
    Table 104. Kemin Biologics Recent Developments/Updates
    Table 105. ZOETIS Corporation Information
    Table 106. ZOETIS Description and Business Overview
    Table 107. ZOETIS Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. ZOETIS Live Attenuated Vaccines for Poultry Product
    Table 109. ZOETIS Recent Developments/Updates
    Table 110. Vaxxinova Corporation Information
    Table 111. Vaxxinova Description and Business Overview
    Table 112. Vaxxinova Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Vaxxinova Live Attenuated Vaccines for Poultry Product
    Table 114. Vaxxinova Recent Developments/Updates
    Table 115. PULIKE Corporation Information
    Table 116. PULIKE Description and Business Overview
    Table 117. PULIKE Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. PULIKE Live Attenuated Vaccines for Poultry Product
    Table 119. PULIKE Recent Developments/Updates
    Table 120. PHIBRO ANIMAL HEALTH CORPORATION Corporation Information
    Table 121. PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
    Table 122. PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product
    Table 124. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
    Table 125. JINYU BIOTECHNOLOGY Corporation Information
    Table 126. JINYU BIOTECHNOLOGY Description and Business Overview
    Table 127. JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product
    Table 129. JINYU BIOTECHNOLOGY Recent Developments/Updates
    Table 130. HARBIN PHARMACEUTICAL GROUP Corporation Information
    Table 131. HARBIN PHARMACEUTICAL GROUP Description and Business Overview
    Table 132. HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product
    Table 134. HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
    Table 135. MEVAC Corporation Information
    Table 136. MEVAC Description and Business Overview
    Table 137. MEVAC Live Attenuated Vaccines for Poultry Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. MEVAC Live Attenuated Vaccines for Poultry Product
    Table 139. MEVAC Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Live Attenuated Vaccines for Poultry Distributors List
    Table 143. Live Attenuated Vaccines for Poultry Customers List
    Table 144. Live Attenuated Vaccines for Poultry Market Trends
    Table 145. Live Attenuated Vaccines for Poultry Market Drivers
    Table 146. Live Attenuated Vaccines for Poultry Market Challenges
    Table 147. Live Attenuated Vaccines for Poultry Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Live Attenuated Vaccines for Poultry
    Figure 2. Global Live Attenuated Vaccines for Poultry Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Live Attenuated Vaccines for Poultry Market Share by Type in 2023 & 2030
    Figure 4. Spray Product Picture
    Figure 5. Eye Drop Product Picture
    Figure 6. Oral Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Live Attenuated Vaccines for Poultry Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Live Attenuated Vaccines for Poultry Market Share by Application in 2023 & 2030
    Figure 10. Chicken
    Figure 11. Cattle
    Figure 12. Horse
    Figure 13. Others
    Figure 14. Global Live Attenuated Vaccines for Poultry Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Live Attenuated Vaccines for Poultry Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Live Attenuated Vaccines for Poultry Sales (2019-2030) & (K Units)
    Figure 17. Global Live Attenuated Vaccines for Poultry Average Price (US$/Unit) & (2019-2030)
    Figure 18. Live Attenuated Vaccines for Poultry Report Years Considered
    Figure 19. Live Attenuated Vaccines for Poultry Sales Share by Manufacturers in 2023
    Figure 20. Global Live Attenuated Vaccines for Poultry Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Live Attenuated Vaccines for Poultry Players: Market Share by Revenue in 2023
    Figure 22. Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Live Attenuated Vaccines for Poultry Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Live Attenuated Vaccines for Poultry Sales Market Share by Country (2019-2030)
    Figure 25. North America Live Attenuated Vaccines for Poultry Revenue Market Share by Country (2019-2030)
    Figure 26. United States Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Live Attenuated Vaccines for Poultry Sales Market Share by Country (2019-2030)
    Figure 29. Europe Live Attenuated Vaccines for Poultry Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Live Attenuated Vaccines for Poultry Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2019-2030)
    Figure 37. China Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Live Attenuated Vaccines for Poultry Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Live Attenuated Vaccines for Poultry Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Live Attenuated Vaccines for Poultry Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Live Attenuated Vaccines for Poultry Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. UAE Live Attenuated Vaccines for Poultry Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Live Attenuated Vaccines for Poultry by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Live Attenuated Vaccines for Poultry by Type (2019-2030)
    Figure 58. Global Live Attenuated Vaccines for Poultry Price (US$/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Live Attenuated Vaccines for Poultry by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Live Attenuated Vaccines for Poultry by Application (2019-2030)
    Figure 61. Global Live Attenuated Vaccines for Poultry Price (US$/Unit) by Application (2019-2030)
    Figure 62. Live Attenuated Vaccines for Poultry Value Chain
    Figure 63. Live Attenuated Vaccines for Poultry Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Killed type Poultry Vaccine Market Research Report 2025
Poultry Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Health Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Gases Sensors Market Research Report 2024
Global Veterinary Diagnostic Products Market Research Report 2024
Global Insect Protein for Animal Feed Market Research Report 2025
Global Animal Blood Plasma and Derivatives Market Research Report 2025
Global Animal Weight Scale Market Research Report 2025
Global Real Time Monitoring Of Pet Wearables Market Research Report 2025
Global Live Animal In Vivo Imaging System Market Research Report 2024
Global Veterinary Blood Analyser Market Research Report 2024
Global Animal Euthanasia System Market Research Report 2025
Global High End Cat Food Market Research Report 2025
Global Veterinary Dynamic Orthosis Support Market Research Report 2024
Global Veterinary Diagnostic Kits Market Research Report 2025
Global Lab Animal Housing Market Research Report 2025
Global Cat Food Subscription Service Market Research Report 2025
Global Pet Consignment Market Research Report 2025
Global Pet Preservation Services Market Research Report 2025
Global Personalized Dog Food Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions